Unifeye Vision Partners has partnered with Brooks Eye Associates, a prominent Texas ophthalmology practice, supported by a capital investment from Morgan Stanley Private Credit to enhance growth and patient care.
Information on the Target
Dallas, Texas-based Unifeye Vision Partners (UVP) has entered into a partnership with Brooks Eye Associates, an esteemed ophthalmology practice and surgery center located in Plano, Texas. Brooks Eye Associates, led by Dr. Dain B. Brooks, has been a staple in the Plano community since 2013, offering a wide range of eye care services such as cataract surgery, advanced refractive procedures, glaucoma treatments, and retinal care. The practice is also noted for its philanthropic involvement, with Dr. Brooks leading humanitarian missions in underserved regions including India, Mexico, and Ecuador, demonstrating a commitment to accessible vision care that complements UVP's core values.
The partnership will enable Brooks Eye Associates to leverage UVP's extensive resources and operational support while continuing to operate with clinical autonomy. The alignment between Brooks Eye Associates' dedication to patient-centered care and UVP's mission to enhance ophthalmic clinical and surgical care underscores the strategic fit of this collaboration.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target's Specific Country
The ophthalmology market in the United States is experiencing significant growth, driven by an aging population and increasing prevalence of eye-related disorders. As advancements in technology enhance the effectiveness and accessibility of su
Similar Deals
New Mountain Capital → Smarter Technologies
2025
Advantage Capital → Gravity Diagnostics
2025
Eir Partners → Porter
2025
Ampersand Capital Partners → Lexington Medical
2025
Ampersand Capital Partners → Gannet BioChem
2025
WestView Capital Partners → PharmaLink
2025
Unifeye Vision Partners
invested in
Brooks Eye Associates
in 2025
in a Growth Equity & Expansion Capital deal